| Avastatin equivalent to Lucentis for treating wet macular degeneration, but much cheaper. |
|
| NEJM: An expensive eye injection that’s approved to treat macular degeneration — the most common cause of age-related blindness — works no better than a much cheaper drug at preventing vision loss. That’s the finding of a long-awaited study published online yesterday by the New England Journal of Medicine. |